In vitro/in vivo effect of Citrus limon (L. Burm. f.) juice on blood parameters, coagulation and anticoagulation factors in rabbits.

The genus Citrus of the family Rutaceae includes many species e.g. Citrus indica, Citrus aurantifolia and Citrus limon, among which Citrus limon L. Burm. f. has been reported to have highest antimicrobial activity. It is used as antidote against certain venom, due to its platelet inhibitory effect and also reported to have hypocholesterolemic effect. However its anticoagulant and thrombolytic effect were not been investigated, hence a prospective in-vitro/in-vivo study was designed to determine the effect of Citrus limon on blood parameters, coagulation and anticoagulation factors. In-vitro tests revealed highly significant increase in thrombin time and activated partial thromboplastin time by Citrus limon, whereas fibrinogen concentration was significantly reduced in comparison to control, however prothrombin time was not affected significantly. In-vivo testing of Citrus limon was done at three different doses i.e. 0.2ml/kg, 0.4ml/kg and 0.6ml/kg in healthy rabbits. Significant changes were observed in hematological parameters such as erythrocytes, hemoglobin and mean corpuscular hemoglobin concentration. Bleeding time and thrombin time was significantly prolonged and there was increase in protein C and thrombin antithrombin complex levels. These results may be due to inactivation of thrombin because it significantly decreases fibrinogen concentration and inhibit platelet aggregation. Citrus limon showed maximal anticoagulant effect at 0.4ml/kg, which suggest that Citrus limon possesses an anti-thrombin component and could prevent thrombosis playing a cardio protective role.

[1]  J. Weigelt.  Surgical critical care. , 2012, The Surgical clinics of North America.

[2]  H. Sharaf,et al.  Assessment of Genotoxicity and Histopathological Changes Induced by Polyethylene Glycol (PEG6000) in Male Mice , 2012 .

[3]  M. McCullough,et al.  Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. , 2012, American Journal of Clinical Nutrition.

[4]  B. Lipe,et al.  Deficiencies of Natural Anticoagulants, Protein C, Protein S, and Antithrombin , 2011, Circulation.

[5]  S. Tomic,et al.  Evaluation of antiaggregatory activity of flavonoid aglycone series , 2011, Nutrition journal.

[6]  Z. Vujic,et al.  Effects of Rutin and Hesperidin and their Al(III) and Cu(II) Complexes on in Vitro Plasma Coagulation Assays , 2011, Molecules.

[7]  W. Miesbach,et al.  Comparison of the fibrinogen Clauss assay and the fibrinogen PT derived method in patients with dysfibrinogenemia. , 2010, Thrombosis research.

[8]  P. Hellstern,et al.  Sources of variation in factor VIII, von Willebrand factor and fibrinogen measurements: implications for detecting deficiencies and increased plasma levels. , 2010, Thrombosis research.

[9]  G. Desideri,et al.  Flavonoids: Antioxidants Against Atherosclerosis , 2010, Nutrients.

[10]  T. Lehtimäki,et al.  Elevated plasma fibrinogen caused by inadequate alpha-linolenic acid intake can be reduced by replacing fat with canola-type rapeseed oil. , 2010, Prostaglandins, leukotrienes, and essential fatty acids.

[11]  Z. Yusof,et al.  Shortened activated partial thromboplastin time, a hemostatic marker for hypercoagulable state during acute coronary event. , 2010, Translational research : the journal of laboratory and clinical medicine.

[12]  S. Basili,et al.  Nutrition, Supplements, and Vitamins in Platelet Function and Bleeding , 2010, Circulation.

[13]  Y. Jeong,et al.  Adding Cilostazol to Dual Antiplatelet Therapy Achieves Greater Platelet Inhibition than High Maintenance Dose Clopidogrel in Patients With Acute Myocardial Infarction: Results of the Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients With AMI (ACCEL-AMI) Study , 2010, Circulation. Cardiovascular interventions.

[14]  D. Moreno,et al.  Natural bioactive compounds of Citrus limon for food and health. , 2010, Journal of pharmaceutical and biomedical analysis.

[15]  R. Khan,et al.  Assessment of anticoagulant effect of evening primrose oil. , 2009, Pakistan journal of pharmaceutical sciences.

[16]  M. Montes-Morán,et al.  Study of the thermal degradation of citrus seeds. , 2009 .

[17]  R. Khan,et al.  Anti inflammatory effect of natural honey on bovine thrombin‐induced oxidative burst in phagocytes , 2009, Phytotherapy research : PTR.

[18]  S. Qiao,et al.  Vitamin C: An immunomodulator that attenuates anaphylactic reactions to soybean glycinin hypersensitivity in a swine model , 2009 .

[19]  Juana Fernández-López,et al.  Antifungal activity of lemon (Citrus lemon L.), mandarin (Citrus reticulata L.), grapefruit (Citrus paradisi L.) and orange (Citrus sinensis L.) essential oils , 2008 .

[20]  M. Hamer,et al.  The accumulative effects of modifiable risk factors on inflammation and haemostasis , 2008, Brain, Behavior, and Immunity.

[21]  H. Yun-Choi,et al.  Anti-platelet effects of flavonoids and flavonoid-glycosides from Sophora japonica , 2008, Archives of pharmacal research.

[22]  Y. Yun,et al.  Enhanced release of sphingosine-1-phosphate from hypercholesterolemic platelets: role in development of hypercholesterolemic atherosclerosis. , 2008, Prostaglandins, leukotrienes, and essential fatty acids.

[23]  R. Chambers,et al.  Coagulation signalling following tissue injury: focus on the role of factor Xa. , 2008, The international journal of biochemistry & cell biology.

[24]  H. Büller,et al.  Development in anticoagulant therapy. , 2008, Critical reviews in oncology/hematology.

[25]  O. Chun,et al.  Serum C-reactive protein concentrations are inversely associated with dietary flavonoid intake in U.S. adults. , 2008, The Journal of nutrition.

[26]  Donghong Liu,et al.  Juice components and antioxidant capacity of citrus varieties cultivated in China , 2008 .

[27]  Alisa S Wolberg,et al.  Thrombin generation and fibrin clot structure. , 2007, Blood reviews.

[28]  M. Yin,et al.  Effect of diallyl trisulfide-rich garlic oil on blood coagulation and plasma activity of anticoagulation factors in rats. , 2007, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[29]  S. Pfister.  Aortic thromboxane receptor deficiency alters vascular reactivity in cholesterol-fed rabbits. , 2006, Atherosclerosis.

[30]  Manickkam Jayakumar,et al.  In vitro antibacterial activity of some plant essential oils , 2006, BMC complementary and alternative medicine.

[31]  R. Chambers,et al.  Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury. , 2006, The Journal of clinical investigation.

[32]  B. Patil,et al.  Citrus juice modulates bone strength in male senescent rat model of osteoporosis. , 2006, Nutrition.

[33]  H. Sies,et al.  Acute consumption of flavanol-rich cocoa and the reversal of endothelial dysfunction in smokers. , 2005, Journal of the American College of Cardiology.

[34]  D. Modi,et al.  Acute and chronic effects of aspirin on hematological parameters and hepatic ferritin expression in mice , 2004 .

[35]  D. Panagiotakos,et al.  The effect of diet enriched with alpha-linolenic acid on soluble cellular adhesion molecules in dyslipidaemic patients. , 2004, Atherosclerosis.

[36]  W. Aird.  Natural anticoagulant inhibitors: activated Protein C. , 2004, Best practice & research. Clinical haematology.

[37]  M. Iinuma,et al.  Anti-platelet and membrane-rigidifying flavonoids in brownish scale of onion , 2003 .

[38]  W. Chandler,et al.  Estimating the rate of thrombin and fibrin generation in vivo during cardiopulmonary bypass. , 2003, Blood.

[39]  J. Petersen,et al.  Stability of prothrombin time and activated partial thromboplastin time tests under different storage conditions. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[40]  C. Takahashi,et al.  Effects of high doses of vitamins C and E against doxorubicin-induced chromosomal damage in Wistar rat bone marrow cells. , 1998, Mutation research.

[41]  R. Aster,et al.  A recombinant soluble form of the integrin alpha IIb beta 3 (GPIIb-IIIa) assumes an active, ligand-binding conformation and is recognized by GPIIb-IIIa-specific monoclonal, allo-, auto-, and drug-dependent platelet antibodies. , 1998, Blood.

[42]  M A Khanin,et al.  Mathematical model for the blood coagulation prothrombin time test. , 1998, Thrombosis research.

[43]  R. Stout,et al.  Measurement of fibrinogen in frozen plasma. , 1997, Thrombosis research.

[44]  M. D. L. Castro,et al.  Light scattering-based determination of fibrinogen in human plasma using an automated continuous system , 1996 .

[45]  W. Sluiter,et al.  Association of plasma fibrinogen levels with coronary artery disease, smoking and inflammatory markers. , 1996, Atherosclerosis.

[46]  M. Berhow,et al.  Developmental and substrate specificity of hesperetin-7-O-glucosyltransferase activity in Citrus limon tissues using high-performance liquid chromatographic analysis , 1995 .

[47]  M. Moriau,et al.  The treatment of severe or recurrent deep venous thrombosis. Beneficial effect of the co-administration of antiplatelet agents with or without rheological effects, and anticoagulants. , 1995, Thrombosis research.

[48]  C. Teng,et al.  Antiplatelet actions of some coumarin compounds isolated from plant sources. , 1992, Thrombosis research.

[49]  J. Loscalzo,et al.  Bleeding time prolongation with streptokinase and its reduction with 1-desamino-8-D-arginine vasopressin. , 1990, Circulation.

[50]  O. Bertrand,et al.  ADP-induced platelet aggregation depends on the conformation or availability of the terminal gamma chain sequence of fibrinogen. Study of the reactivity of fibrinogen Paris 1. , 1987, Blood.

[51]  E. Bowie,et al.  Aspirin, Platelets, and Bleeding , 1969, Circulation.

[52]  A. Clauss,et al.  Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens , 1957 .

[53]  A. Siddiq,et al.  EVALUATION OF HYPOLIPIDEMIC EFFECT OF CITRUS LEMON , 2010 .

[54]  Kenji Suda,et al.  Usefulness of high-concentration calcium chloride solution for correction of activated partial thromboplastin time (APTT) in patients with high-hematocrit value. , 2008, Thrombosis research.

[55]  S. Giammanco,et al.  Citrus Flavonoids: molecular structure, biological activity and nutritional properties: a review , 2007 .

[56]  Paul J. Harrison,et al.  Measuring antiplatelet drug effects in the laboratory. , 2007, Thrombosis research.

[57]  T. Monticello,et al.  Quantification of platelet composition in experimental venous thrombosis by real-time polymerase chain reaction. , 2007, Thrombosis research.

[58]  J. Huntington,et al.  Directing thrombin. , 2005, Blood.

[59]  Hyun Pyo Kim,et al.  Anti-inflammatory plant flavonoids and cellular action mechanisms. , 2004, Journal of pharmacological sciences.

[60]  V. Ruíz-Gutiérrez,et al.  Effects of different dietary oils on inflammatory mediator generation and fatty acid composition in rat neutrophils. , 2004, Metabolism: clinical and experimental.

[61]  K. Mann,et al.  The dynamics of thrombin formation. , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[62]  C. Lemini,et al.  Standardization of rat blood clotting tests with reagents used for humans. , 2001, Proceedings of the Western Pharmacology Society.

[63]  R. Heethaar,et al.  Red blood cell size is important for adherence of blood platelets to artery subendothelium. , 1983, Blood.

[64]  A. Clauss.  [Rapid physiological coagulation method in determination of fibrinogen]. , 1957, Acta haematologica.

[65]  Martine,et al.  ADP-Induced Platelet Aggregation Depends on the Conformation or Availability of the Terminal Gamma Chain Sequence of Fib rinogen , 2022 .